Holzer Holzer & Fistel, LLC announces that it is investigating potential breaches of fiduciary duty by certain officers and directors of Chemed Corp. (“Chemed” or the “Company”) (NYSE: CHE). On January 12, 2012, an institutional investor filed a class action lawsuit in the Southern District of Ohio alleging that Chemed violated the federal securities laws between February 15, 2010 and November 16, 2011 (the “Class Period”). The lawsuit alleges, among other things, that throughout the Class Period Chemed fraudulently billed Medicare for hospice services for patients who did not qualify for hospice. According to the complaint, this allegedly fraudulent scheme resulted in Chemed overstating its financial results during the Class Period.

Holzer Holzer & Fistel, LLC’s investigation seeks to determine if the allegations contained in the class action complaint also give rise to separate claims for breaches of fiduciary duty.

If you have continuously held shares since at least February 15, 2010, and plan to continue to hold at least some shares of CHE, and would like to discuss your legal rights, you may contact Michael I. Fistel, Jr., Esq. or Marshall P. Dees, Esq. via email at mfistel@holzerlaw.com, or mdees@holzerlaw.com, or via toll-free telephone at (888) 508-6832.

Holzer Holzer & Fistel, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer Holzer & Fistel, LLC has paid for the dissemination of this promotional communication, and Michael I. Fistel, Jr. is the attorney responsible for its content.

Chemed (NYSE:CHE)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Chemed Charts.
Chemed (NYSE:CHE)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Chemed Charts.